Skip to content
PubMed This is a summary of 39 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 39 referenced papers

Top Authors

Ralf Paschke
University of Calgary
Takashi Akamizu
Kuma Hospital
Katarina Trebušak Podkrajšek
University of Ljubljana
Eijun Nishihara
Kuma Hospital
Akira Miyauchi
Kuma Hospital
Shuji Fukata
Kuma Hospital
Magdalena Avbelj Stefanija
University of Ljubljana

Top Institutions

Ranked by publications Top 6 institutions
02

The Catholic University of Korea Seoul St. Mary's Hospital

Seoul, South Korea

3 papers
03

Kuma Hospital

Kobe, Japan

3 papers
05

Boston Children's Hospital

Boston, United States

2 papers
06

Ljubljana University Medical Centre

Ljubljana, Slovenia

2 papers

References

References (39)
  1. 1

    Novel germline mutation (Leu512Met) in the thyrotropin receptor gene (TSHR) leading to sporadic non-autoimmune hyperthyroidism.

    Roberts SA, Moon JE, Dauber A, Smith JR

    Journal of pediatric endocrinology & metabolism : JPEM 2017; (30(3)):343-347.

    PMID: 28195550
  2. 2

    Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work.

    Kleinau G, Worth CL, Kreuchwig A, et al.

    Frontiers in endocrinology 2017; (8()):86 doi:10.3389/fendo.2017.00086.

    PMID: 28484426
  3. 3

    Inheritable and sporadic non-autoimmune hyperthyroidism.

    Ferraz C, Paschke R

    Best practice & research. Clinical endocrinology & metabolism 2017; (31(2)):265-275 doi:10.1016/j.beem.2017.04.005.

    PMID: 28648513
  4. 4

    Nonautoimmune congenital hyperthyroidism due to p.Asp633Glu mutation in the TSHR gene.

    Cho WK, Ahn MB, Jang W, et al.

    Annals of pediatric endocrinology & metabolism 2018; (23(4)):235-239 doi:10.6065/apem.2018.23.4.235.

    PMID: 30599487
  5. 5

    Thyroid vascularization is an important ultrasonographic parameter in untreated Graves' disease patients.

    Vita R, Di Bari F, Perelli S, et al.

    Journal of clinical & translational endocrinology 2019; (15()):65-69 doi:10.1016/j.jcte.2019.01.001.

    PMID: 30792955
  6. 6

    A CASE OF FAMILIAL NONAUTOIMMUNE HYPERTHYROIDISM DURING PREGNANCY.

    Okazaki Y, Arata N, Umehara N, et al.

    AACE clinical case reports 2020; (6(2)):e94-e97 doi:10.4158/ACCR-2019-0361.

    PMID: 32524019
  7. 7

    The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 1: Hyperthyroidism.

    Mariani G, Tonacchera M, Grosso M, et al.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021; (62(3)):304-312 doi:10.2967/jnumed.120.243170.

    PMID: 33008929
  8. 8

    Familial neonatal nonautoimmune hyperthyroidism due to a gain-of-function (D619G) thyrotropin-receptor mutation.

    Taha D, Adhikari A, Flore LA

    Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(2)):267-271 doi:10.1515/jpem-2020-0291.

    PMID: 33180037
  9. 9

    An A627V-activating mutation in the thyroid-stimulating hormone receptor gene in familial nonautoimmune hyperthyroidism.

    Shin JH, Seo GH, Oh SH, et al.

    Annals of pediatric endocrinology & metabolism 2020; (25(4)):282-286 doi:10.6065/apem.2040076.038.

    PMID: 33401884
  10. 10

    Central TSH Dysregulation in a Patient with Familial Non-Autoimmune Autosomal Dominant Hyperthyroidism Due to a Novel Thyroid-Stimulating Hormone Receptor Disease-Causing Variant.

    Suput Omladic J, Pajek M, Groselj U, et al.

    Medicina (Kaunas, Lithuania) 2021; (57(3)) doi:10.3390/medicina57030196.

    PMID: 33669123
  11. 11

    Familial Non-autoimmune Hyperthyroidism in Family Members Across Four Generations Due To a Novel Disease-causing Variant in The Thyrotropin Receptor Gene.

    Malej A, Avbelj Stefanija M, Bratanič N, Trebušak Podkrajšek K

    Balkan journal of medical genetics : BJMG 2020; (23(2)):87-92 doi:10.2478/bjmg-2020-0022.

    PMID: 33816077
  12. 12

    Novel presentation of the c.1856A > G (p.Asp619Gly) TSHR gene-activating variant: relapsing hyperthyroidism in three subsequent generations manifesting in early childhood and an in vitro functional study.

    Bezdicka M, Kleiblova P, Soucek J, et al.

    Hormones (Athens, Greece) 2021; (20(4)):803-812 doi:10.1007/s42000-021-00299-x.

    PMID: 34142359
  13. 13

    Hyperfunctioning Papillary Thyroid Carcinoma with a BRAF Mutation: The First Case Report and a Literature Review.

    Shinkai S, Ohba K, Kakudo K, et al.

    European thyroid journal 2021; (10(3)):262-267 doi:10.1159/000513552.

    PMID: 34178713
  14. 14

    Report of a family with three generations of undiagnosed familial nonautoimmune hyperthyroidism.

    Stephenson A, Punjwani Z, Eszlinger M, et al.

    Endocrinology, diabetes & metabolism case reports 2021; (2021()).

    PMID: 34866058
  15. 15

    2022 European Thyroid Association Guideline for the management of pediatric Graves' disease.

    Mooij CF, Cheetham TD, Verburg FA, et al.

    European thyroid journal 2022; (11(1)).

    PMID: 34981748
  16. 16

    Performance of Thyroid-Stimulating Immunoglobulin Bioassay and Thyrotropin-Binding Inhibitory Immunoglobulin Assay for the Diagnosis of Graves' Disease in Patients With Active Thyrotoxicosis.

    Silva de Morais N, Angell TE, Ahmadi S, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2022; (28(5)):502-508 doi:10.1016/j.eprac.2022.01.007.

    PMID: 35091101
  17. 17

    The Prediction Model Using Thyroid-stimulating Immunoglobulin Bioassay For Relapse of Graves' Disease.

    Baek HS, Lee J, Jeong CH, et al.

    Journal of the Endocrine Society 2022; (6(5)):bvac023 doi:10.1210/jendso/bvac023.

    PMID: 35441120
  18. 18

    Thyroid Storm Caused by Hyperemesis Gravidarum.

    Zimmerman CF, Ilstad-Minnihan AB, Bruggeman BS, et al.

    AACE clinical case reports 2022; (8(3)):124-127 doi:10.1016/j.aace.2021.12.005.

    PMID: 35602873
  19. 19

    Autoantibody mimicry of hormone action at the thyrotropin receptor.

    Faust B, Billesbølle CB, Suomivuori CM, et al.

    Nature 2022; (609(7928)):846-853 doi:10.1038/s41586-022-05159-1.

    PMID: 35940205
  20. 20

    A case of Hashimoto's thyroiditis following Graves' disease.

    Oueslati I, Salhi S, Yazidi M, et al.

    Clinical case reports 2022; (10(10)):e6466 doi:10.1002/ccr3.6466.

    PMID: 36254153
  21. 21

    A Novel TSH Receptor Gene Variant Associated with Non-Autoimmune Hyperthyrotropinemia: A Case Report.

    Piva I, Censi S, Manso J, et al.

    Endocrine, metabolic & immune disorders drug targets 2024; (24(2)):273-276 doi:10.2174/1871530323666230824153915.

    PMID: 37622708
  22. 22

    Hyperthyroidism: A Review.

    Lee SY, Pearce EN

    JAMA 2023; (330(15)):1472-1483 doi:10.1001/jama.2023.19052.

    PMID: 37847271
  23. 23

    Long-Term Disproportional TSH Hyposecretion in a Patient With Nonautoimmune Hyperthyroidism After Radioiodine Therapy.

    Nishihara E, Fukata S, Miyauchi A, Akamizu T

    JCEM case reports 2023; (1(2)):luad026 doi:10.1210/jcemcr/luad026.

    PMID: 37908476
  24. 24

    A Novel TSHR Gene Mutation in a Family with Non-autoimmune Hyperthyroidism.

    Kufoof T, Luxford C, Kannangara K, et al.

    Medical archives (Sarajevo, Bosnia and Herzegovina) 2024; (78(2)):154-158 doi:10.5455/medarh.2024.78.154-158.

    PMID: 38566871
  25. 25

    Familial Nonautoimmune Hyperthyroidism Due to a TSH Receptor Gene Pathogenic Variant.

    Takahashi S, Nishihara E, Fukata S, et al.

    JCEM case reports 2024; (2(10)):luae167 doi:10.1210/jcemcr/luae167.

    PMID: 39301178
  26. 26

    Controversies Surrounding IGF-I Receptor Involvement in Thyroid-Associated Ophthalmopathy.

    Smith TJ

    Thyroid : official journal of the American Thyroid Association 2025; (35(3)):232-244 doi:10.1089/thy.2024.0606.

    PMID: 39909461
  27. 27

    Familial Non-Autoimmune Hyperthyroidism Caused by an Extracellular Domain Variant (p.Leu267Phe) of the TSH Receptor.

    Shimura K, Ichihashi Y, Abe K, et al.

    Hormone research in paediatrics 2026; (99(5)):623-631 doi:10.1159/000544836.

    PMID: 39987906
  28. 28

    Mild Thyrotoxicosis due to Seronegative Graves' Disease or Disseminated Thyroid Autonomy.

    Charbonne G, Hallak F, Rivera Cruz AE, McDonald SD

    AACE clinical case reports 2025; (11(2)):102-106 doi:10.1016/j.aace.2024.12.002.

    PMID: 40201472
  29. 29

    Performance of the Siemens' thyroid stimulating immunoglobulin assay in the diagnosis of hyperthyroidism: Prospective cohort study.

    Kline GA, Proctor DT, Moledina N, et al.

    Clinical biochemistry 2025; (137()):110938 doi:10.1016/j.clinbiochem.2025.110938.

    PMID: 40286898
  30. 30

    Genotype-Phenotype Correlation in Germline TSH Receptor Activating Mutation Associated Hyperthyroidism: A Systematic Review.

    Yamichannaiah C, Memon SS, Sarathi V, et al.

    Clinical endocrinology 2025; (103(2)):119-128 doi:10.1111/cen.15288.

    PMID: 40470728
  31. 31

    Delayed Presentation With Atypical Extrathyroidal Manifestations of Sporadic Non-autoimmune Congenital Hyperthyroidism: A Case Report and Literature Review.

    Dighe R, Jain V, Aggarwal A, Kulshreshtha B

    Cureus 2025; (17(8)):e91040 doi:10.7759/cureus.91040.

    PMID: 41018437
  32. 32

    Severe Phenotype of De Novo TSHR Activating Pathogenic Variants.

    Torrey AC, Zuccaro M, Steinman JB, et al.

    Case reports in endocrinology 2025; (2025()):2254609 doi:10.1155/crie/2254609.

    PMID: 41064600
  33. 33

    A de novo pathogenic variant in TSHR expanding the phenotype of persistent sporadic congenital non-autoimmune hyperthyroidism: a case report and literature review.

    Xu W, Liu X

    Translational pediatrics 2025; (14(10)):2850-2859 doi:10.21037/tp-2025-380.

    PMID: 41216432
  34. 34

    Non-autoimmune Familial Hyperthyroidism in Children: The Importance of Genetic Testing.

    Sa Pinto M, Ferrão T, Dias Preda A, et al.

    Cureus 2026; (18(1)):e100624 doi:10.7759/cureus.100624.

    PMID: 41631090
  35. 35

    Diagnostic discordance and performance of third-generation competitive TRAb vs. sandwich TSI ELISA in the diagnosis of Graves' disease.

    Naser Abed M, Abdul Khaliq RJ

    Scandinavian journal of clinical and laboratory investigation 2026; (86(4)):355-360 doi:10.1080/00365513.2026.2669918.

    PMID: 42112605
  36. 36

    Surgical considerations for adult Graves' disease: a narrative review of indications, perioperative challenges and postoperative outcomes.

    Bartalena L, Gallo D, Piantanida E, Tanda ML

    Expert review of endocrinology & metabolism 2026; (21(4)):271-289 doi:10.1080/17446651.2026.2676876.

    PMID: 42169504
  37. 37

    Non-Autoimmune Hyperthyroidism Associated With a Novel Germline Mutation (D633N) in the TSH Receptor.

    Mori S, Osaki Y, Fukazawa H, et al.

    Case reports in endocrinology 2026; (2026()):3274433 doi:10.1155/crie/3274433.

    PMID: 42367683
  38. 38

    TSHR Gly413Ser in familial nonautoimmune hyperthyroidism: a case report.

    Kelp O, Førsvoll J, Bischof F, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2026; doi:10.1515/jpem-2025-0617.

    PMID: 42665942
  39. 39

    Neonatal Hyperthyroidism Due to TSHR p.Thr632Ile Variant With a Suggestive Familial Pattern.

    Resnick O, Chandler O, Beauchamp G

    AACE endocrinology and diabetes 2026; (13(5)):673-676 doi:10.1016/j.aed.2026.06.007.

    PMID: 42978834